There is evidence of people taking GLP-1 drugs reporting changes in their cravings for certain foods, like sweets
The MHRA has not issued specific guidance on NAD+ supplements in the context of GLP-1 therapies, but its broader messaging encourages consumers to exercise caution with unregulated products and to seek professional advice before combining supplements with any medicine
Yennu Nanda VG, Gammon S, Prasad R, Knighton B, Pisaneschi F, Feng N, Williams L, Pramanik S, Sudderth J, Sui D, Fischer GM, Deng W, Peng W, Wang J, McQuade JL, Tetzlaff M, Di Francesco ME, Marszalek J, Piwnica-Worms D, DeBerardinis RJ, Davies MA
Disclaimer: This illustration is provided solely for informational purposes and is not intended as a substitute for professional medical advice